Notice Number: NOT-NS-19-035
Key Dates
Release Date : February 05, 2019
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
National Eye Institute (NEI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Purpose
The purpose of this notice is to inform interested applicants of a change to IC and NIH Office of Interest Areas and Specific Requirements for RFA-NS-19-009 "Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trial Optional)". The IC and NIH Office of Interest Areas and Specific Requirements have been modified to include information that was erroneously omitted. IC-specific Areas of Interest and Specific Requirements have been added for the National Eye Institute (NEI), the National Institute on Alcohol Abuse (NIAAA) and the National Institute on Aging (NIA).
Currently Reads:
Part 2. Full Text Announcement
Section I. Funding Opportunity Description
IC and NIH Office Interest Areas and Specific Requirements
Understanding the basic science of music and exploring its potential to enhance health and treat disease is relevant to the mission of the NIH Institutes participating in this FOA. Below is a list of areas that are of particular interest to participating ICs:
NCCIH: The National Center for Complementary and Integrative Health (NCCIH) is broadly interested in supporting research aimed at understanding the mechanisms by which music and music interventions impact symptom management in high-priority topics such as pain, stress-related disorders, sleep disorders. NICCH is also interested in how music and music intervention could be used to address opioid misuse and enhancement of emotional well-being. In addition to basic animal model work, NCCIH supports mechanistic clinical trials under this FOA. However, NCCIH will not support grant applications proposing efficacy or effectiveness research with primary clinical outcomes under this FOA. Investigators who are ready to propose a fully powered efficacy or effectiveness clinical trials can apply to PAR-18-662 with a companion application to PAR-18-663 for an independent data coordinating center. Investigators are strongly encouraged to contact program staff to discuss their aims prior to submission.
Modified to Read:
Part 2. Full Text Announcement
Section I. Funding Opportunity Description
IC and NIH Office Interest Areas and Specific Requirements
Understanding the basic science of music and exploring its potential to enhance health and treat disease is relevant to the mission of the NIH Institutes participating in this FOA. Below is a list of areas that are of particular interest to participating ICs:
NEI: The National Eye Institute (NEI) supports research that addresses blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and the special health problems and requirements of the blind. Under this FOA, NEI will accept applications that propose to examine how music affects the fundamental mechanisms of visual function or loss of vision, which may inform development of music-based interventions for the visually impaired. Topics of interest include, but are not restricted to, the role of music in neural reorganization and plasticity in the visually impaired; the impact of music on sensory substitution, navigation/mobility, and functional strategies in the visually impaired; and music integration in low vision rehabilitation.NCCIH: The National Center for Complementary and Integrative Health (NCCIH) is broadly interested in supporting research aimed at understanding the mechanisms by which music and music interventions impact symptom management in high-priority topics such as pain, stress-related disorders, sleep disorders. NICCH is also interested in how music and music intervention could be used to address opioid misuse and enhancement of emotional well-being. In addition to basic animal model work, NCCIH supports mechanistic clinical trials under this FOA. However, NCCIH will not support grant applications proposing efficacy or effectiveness research with primary clinical outcomes under this FOA. Investigators who are ready to propose a fully powered efficacy or effectiveness clinical trials can apply to PAR-18-662 with a companion application to PAR-18-663 for an independent data coordinating center. Investigators are strongly encouraged to contact program staff to discuss their aims prior to submission.
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Robert Riddle, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone:301-496-5745
Email: [email protected]